Your browser doesn't support javascript.
loading
Correction To: Serplulimab, a novel anti-PD-1 antibody, in patients with microsatellite instability-high solid tumours: an open-label, single-arm, multicentre, phase II trial.
Qin, Shukui; Li, Jin; Zhong, Haijun; Jin, Chuan; Chen, Lili; Yuan, Xianglin; Fan, Qingxia; Chen, Kehe; Cao, Peiguo; Xiao, Jianjun; Jiang, Da; Zhang, Tao; Zhang, Hongyu; Wang, Xicheng; Wang, Wei; Han, Lin; Wang, Qingyu; Zhu, Jun.
Afiliação
  • Qin S; Department of Oncology, Qinhuai Medical Area, Eastern Theater General Hospital of PLA China, Nanjing, China.
  • Li J; Department of Oncology, Tongji University Shanghai East Hospital, Shanghai, China. lijin@csco.org.cn.
  • Zhong H; Department of Abdominal Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China.
  • Jin C; Department of Oncology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China.
  • Chen L; Department of Hematology and Oncology, Taizhou First People's Hospital, Taizhou, China.
  • Yuan X; Department of Oncology, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.
  • Fan Q; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Chen K; Department of Oncology, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
  • Cao P; Department of Oncology, The Third Xiangya Hospital of Central South University, Changsha, China.
  • Xiao J; Chemotherapeutic Department, Zhongshan City People's Hospital, Zhongshan, China.
  • Jiang D; Department of Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Zhang T; Department of Oncology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Zhang H; Cancer Center, The Fifth Affiliated Hospital Sun Yat-sen University, Zhuhai, China.
  • Wang X; Department of Oncology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China.
  • Wang W; Department of Gastrointestinal Oncology, The First People's Hospital of Foshan, Foshan, China.
  • Han L; Shanghai Henlius Biotech, Inc., Shanghai, China.
  • Wang Q; Shanghai Henlius Biotech, Inc., Shanghai, China.
  • Zhu J; Shanghai Henlius Biotech, Inc., Shanghai, China.
Br J Cancer ; 127(12): 2249, 2022 Dec.
Article em En | MEDLINE | ID: mdl-36323881

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Idioma: En Revista: Br J Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Idioma: En Revista: Br J Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China